Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tivic Health Systems (TIVC) Cash & Equivalents (2021 - 2025)

Tivic Health Systems has reported Cash & Equivalents over the past 5 years, most recently at $3.5 million for Q3 2025.

  • Quarterly results put Cash & Equivalents at $3.5 million for Q3 2025, up 63.86% from a year ago — trailing twelve months through Sep 2025 was $3.5 million (up 63.86% YoY), and the annual figure for FY2024 was $1.8 million, down 44.5%.
  • Cash & Equivalents for Q3 2025 was $3.5 million at Tivic Health Systems, up from $975000.0 in the prior quarter.
  • Over the last five years, Cash & Equivalents for TIVC hit a ceiling of $12.8 million in Q1 2021 and a floor of $700000.0 in Q1 2025.
  • Median Cash & Equivalents over the past 5 years was $3.5 million (2022), compared with a mean of $5.0 million.
  • Biggest five-year swings in Cash & Equivalents: plummeted 76.01% in 2023 and later soared 70.43% in 2024.
  • Tivic Health Systems' Cash & Equivalents stood at $12.8 million in 2021, then crashed by 72.51% to $3.5 million in 2022, then decreased by 7.79% to $3.2 million in 2023, then crashed by 44.5% to $1.8 million in 2024, then surged by 94.44% to $3.5 million in 2025.
  • The last three reported values for Cash & Equivalents were $3.5 million (Q3 2025), $975000.0 (Q2 2025), and $700000.0 (Q1 2025) per Business Quant data.